↓ Skip to main content

Ketamine prescribing after an RCT

Overview of attention for article published in Internal Medicine Journal, June 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

blogs
1 blog
twitter
6 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
70 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ketamine prescribing after an RCT
Published in
Internal Medicine Journal, June 2014
DOI 10.1111/imj.12442
Pubmed ID
Authors

J. R. Hardy, O. Spruyt, S. J. Quinn, L. R. Devilee, D. C. Currow

Abstract

An adequately powered, double-blind, multisite, randomised controlled trial has shown no net clinical benefit for subcutaneous ketamine over placebo in the management of cancer pain refractory to combination opioid and co-analgesic therapy. The results of the trial were disseminated widely both nationally and internationally.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Unknown 69 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 16%
Other 8 11%
Student > Doctoral Student 8 11%
Student > Ph. D. Student 7 10%
Student > Bachelor 5 7%
Other 13 19%
Unknown 18 26%
Readers by discipline Count As %
Medicine and Dentistry 25 36%
Nursing and Health Professions 8 11%
Psychology 7 10%
Neuroscience 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 4 6%
Unknown 22 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 July 2021.
All research outputs
#2,879,731
of 24,542,484 outputs
Outputs from Internal Medicine Journal
#233
of 2,465 outputs
Outputs of similar age
#28,029
of 233,159 outputs
Outputs of similar age from Internal Medicine Journal
#2
of 29 outputs
Altmetric has tracked 24,542,484 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,465 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 233,159 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.